Opens in a new tab

IMPORTANT: Please note that brynmawrurology.com is an imposter website and NOT affiliated with MidLantic Urology. No one from our practice will contact you from or direct you to that website. If you interact with that site, no one from our practice will be aware.

Back to Blogs

Groundbreaking Diagnostics and Treatments in Bladder Cancer

By: David B. Cahn, DO, MBS, FACOS

Here’s something you might not know about bladder cancer: the symptoms.

Worldwide, 54% of bladder cancer patients were unaware of the symptoms of the disease before diagnosis, according to the World Bladder Cancer Patient Coalition. Had these cancer patients known, the five-year survival rate might be well above 79% (U.S.).

Still, incidences of bladder cancer have slipped by about 1% annually in recent years, and death rates from the disease also are down.

Raised awareness from efforts such the World Bladder Cancer Patient Coalition’s study and Bladder Health Awareness Month might help explain the improvements. The attention certainly contributes to advancements in life-saving treatments.

So, what do you know about bladder cancer, or even your bladder?

 

Visit our updated Bladder Cancer web page here.

About the Bladder: It’s Location, Functions, and Conditions

The bladder is a muscular, balloon-like organ that serves as a urine reservoir, slowly expanding as it fills – to about 6 inches from 2 inches. It’s located between your hip bones and collects urine through two tubes (ureters) that connect to the kidneys, which make urine by filtering your blood.

Your bladder’s only function is to store and then release urine, about 1.5 to 2 cups on average. When it gets close to this point, the brain sends signals to the bladder to squeeze is muscles and push out the urine, while alerting you to find a bathroom.

In a healthy bladder, this occurs up to eight times a day.

How Bladder Cancer Develops, and Risks

All of your body’s cells contain DNA, the carrier of genetic information, and it is not uncommon for gene changes to occur in that DNA. These changes can be inherited or acquired, such as from chemical or toxin exposure, or simply by mistakes that occur when a cell divides.

Often, your body can fix such changes. However, if a mutation builds in the DNA over a period of time, the DNA’s instructions can go haywire and the normal cells become cancer cells. Instead of growing manageably, they reproduce uncontrollably without dying, developing into invasive tissue, or tumors.

With bladder cancer, the tumors develop in the bladder lining or the urethra. These tumors are classified by grade (aggressiveness) and the extent of their invasion within or beyond the bladder wall (stage).

If the cancer has spread into the deeper muscle layers of the bladder wall, it is called muscle-invasive bladder cancer (MIBC). If the cancer has not invaded the bladder wall, it is called non-muscle invasive bladder cancer (NMIBC).

Key risk factors for bladder cancer include being older than 55; gender (men account for 75% of all cases); smoking (smokers are three time as likely to develop bladder cancer than non-smokers); and extended exposure to industrial chemicals, according to the American Cancer Society.

Also, patients who have undergone pelvic area radiation therapy or taken the chemotherapy drug Cytoxan might be at greater risk of developing bladder cancer.

The Signs and Symptoms of Bladder Cancer

Many people might not know the signs of bladder cancer, but the symptoms do tend to appear in the early stages, due to the bladder’s single function. Red-flag symptoms of bladder cancer (early or advanced) include:

  • Blood in the urine (hematuria)
  • More frequent and urgent urination
  • Trouble passing urine or a weak stream
  • Bladder (lower pelvic) pain
  • Loss of appetite (advanced cancer)
  • Fatigue and weakness (advanced cancer)
  • Bone pain (advanced cancer)

Diagnosing Bladder Cancer and Its Stages

Should any of the above symptoms arise in you, it is likely time to get tested by an expert. A urologist and/or oncologist can perform a series of diagnostic tests to detect bladder cancer or other urinary tract abnormalities. These tests include:

  • Urine screenings for blood or infection.
  • Lab work to evaluate urine cells for cancer.
  • A blood test to assess kidney function.
  • Advanced imaging including a CT scan, MRI, and/or internal evaluation using a camera-equipped scope through the urethra (cystoscopy). In some cases, physicians may order a specialized imaging called a FDG PET/CT scan, which produces cellular-level imagery.
  • In instances where a tumor is detected, removing the growth and surrounding bladder muscle to test for cancer and, if present, its progress. This procedure is called a transurethral resection of bladder tumor (TURBT).

Test results should help indicate the cancer’s stage, or amount of cancer in the body. Your cancer team will determine how far the cancer is spread using a three-factor staging system, called the TNM system:

  • T describes the primary tumor’s grown.
  • N gauges whether the cancer has spread to nearby lymph nodes.
  • M assesses if the cancer has progressed to other organs or more distant lymph nodes (metastasized).

Numbers or letters might follow the T, N, or M to indicate the cancer’s progress, with higher numbers signifying more-advanced cancer. These range from T1 (localized cancers) to T4 (metastatic).

  • Localized (T1) cancers – These tumors exist only under the lining of the bladder and have not grown into the wall’s muscle layer.
  • Next-stage (T3 and T 4) cancers – The tumors have expanded to the bladder muscle (T2) and beyond to surrounding tissue, including the prostate, uterus, or vagina (T3).
  • Advanced (T4) cancers – Malignancies that have progressed to the lymph nodes, pelvic wall, and/or abdominal wall.

Leading-Edge Treatments in Bladder Cancer

You doctor will prescribe treatment options based on your cancer stage and grade, symptom severity, and the likelihood of recurrence.

For non- muscle-invasive bladder cancer:

Surgical removal:

Typically, the first step to treating early-stage bladder cancer is surgical removal through a TURBT, which might have already been performed as part of the diagnostic process. In this minimally invasive procedure, a slim tube-like instrument is inserted through the urethra and removes the tissue. The patient then undergoes immunotherapy treatment delivered directly into the bladder (intravesical). The immunotherapy, called BCG (Bacillus Calmette-Guerin), triggers the patient’s immune system to attack the cancer cells.

Intravesical therapies (non-surgical):

Some patients with early-stage NMIBC bladder cancer might be candidates for direct-to-bladder drug therapies that enable the patient to avoid bladder removal and its side effects. These include immunotherapies, gene therapies, and chemotherapies. Among the options:

  • The drugs Anktiva, Keytruda (both immunotherapies), and Adstiladrin (a gene therapy). These treatments are often recommended for patients who do not respond to BCG immunotherapy.
  • Intravesical chemotherapies. These include Inlexzo, which slow-releases directly into the tumor over a 21-day period; and Zusduri, a prescription gel that that adheres to the bladder wall for several hours, killing the DNA function in cancer cells over (usually) six weekly treatments.

For muscle-invasive bladder cancer:

More extensive treatment is necessary to treat cancer that has penetrated the bladder muscle. Depending on the cancer’s progression, options include:

  • Transurethral resection of the bladder tumor (TURBT) with radiation – If the initial TURBT shows the cancer has progressed into the bladder muscle, the cancer team will follow with a second surgery to remove as much as the tumor as possible, followed by radiation therapy to kill the remaining cancer cells.
  • Immunotherapies – These drugs program your body’s immune cells to attack cancer cells, but are administered in oral or injection form rather than intravesically.
  • Radical cystectomy ­– Surgically removing the entire bladder, the nearby lymph nodes, and possibly nearby organs. This procedure can be performed robotically, for a smaller incision and faster recovery. The bladder may be replaced with a “neo-bladder” made from part of your intestine.

Clinical trial options:

MidLantic Urology performs a number of clinical research trials into muscle-invasive and non-muscle invasive bladder cancer treatments, including intravesical drug therapies. These programs contribute significantly to advancements that can benefit all cancer patients and they all follow strict regulatory guidelines. Learn more about our available clinical trials here.

Make This Bladder Health Awareness Month Count

Bladder cancer can develop in anyone, whether they know it or not, but you can limit your risks. Act on the symptoms, see a urologist, and talk to others about bladder cancer to raise awareness. You could save someone.

To talk to a specialist about bladder discomfort and other symptoms, you can request an appointment at one of our convenient locations here. If you want to learn about clinical research into bladder cancer at MidLantic Urology, click here.

Schedule an appointment with a MidLantic Urology Physician near you today!

Request An Appointment